Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19618183 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients
Condition: Neuroendocrine Carcinoma
Intervention: Drug: 68Ga-DOTATATE PET Scan

Indicates status has not been verified in more than two years